The oncology landscape is experiencing a dramatic realignment as a wave of groundbreaking drug approvals arrives across the field. These cutting-edge therapies, targeting specific pathways within cancer cells, offer encouraging results for patients battling a range of challenging diseases. Ongoing investigations have demonstrated significant improv